Bisphosphonates and breast carcinoma
The skeleton is a common site of breast carcinoma metastasis; 75% of patients with breast carcinoma demonstrate bone metastases at autopsy. The lytic destruction of bone in these patients is due to excessive osteoclastic activity. By reducing osteoclastic activity, bisphosphonates inhibit bone resor...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
1997
|
| On-line přístup: | https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1668::aid-cncr17>3.3.co;2-5 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819971015%2980%3A8%20%3C1668%3A%3AAID-CNCR17%3E3.0.CO%3B2-Y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|